Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04209660
Title Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland Cancers
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

adenoid cystic carcinoma

salivary gland cancer

Therapies

Lenvatinib + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Baptist Alliance MCI Recruiting Miami Florida 33143 United States Details
Memoral Sloan Kettering Basking Ridge (All Protocol Activities) Recruiting Basking Ridge New Jersey 07920 United States Details
Memoral Sloan Kettering Monmouth (All protocol activities) Recruiting Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Bergen (All Protocol Activities) Recruiting Montvale New Jersey 07645 United States Details
Memorial Sloan Kettering Commack (All Protocol Activities) Recruiting Commack New York 11725 United States Details
Memorial Sloan Kettering Westchester (All Protocol Activities) Recruiting Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center (All Protocol Activities) Recruiting New York New York 10065 United States Details
Memorial Sloan Kettering Nassau (All Protocol Activities) Recruiting Uniondale New York 11553 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field